July 9, 2021 – Echolight Medical (Seattle, WA) was awarded a multi-year contract with Vizient Inc. (Irving, TX) to make its Radiofrequency Echographic Multi Spectrometry (REMS) technology available at contracted pricing to its members.
REMS is the first clinically available method for the direct non-ionizing measurement of BMD at the femur and lumbar spine. According to the company, the device’s portability allows for screening and monitoring of patients’ bone health at the point-of-care, improving early diagnosis and prevention of osteoporosis-related fractures.
Widely used throughout Europe, REMS is a radiation-free technology delivered using a portable bone densitometer that can safely monitor key bone health indicators with greater frequency than other testing methods, the company says.
Within minutes, REMS provides a patient’s bone health scores and an assessment of their future fracture risk.
Echolight, founded in Italy in 2011, recently expanded its global reach to the United States with the opening of its Seattle headquarters in 2020.